Leena Peltonen-Palotie
Leena Peltonen-Palotie (1952–2010) was a Finnish geneticist who made significant contributions to the field of human genetics. She is best known for her work on the genetics of human diseases, particularly those that are common in Finland due to the country's unique genetic heritage.
Early Life and Education[edit]
Peltonen-Palotie was born in Helsinki, Finland, in 1952. She completed her undergraduate studies at the University of Helsinki, where she also earned her PhD in molecular genetics in 1978.
Career[edit]
After completing her PhD, Peltonen-Palotie worked as a postdoctoral researcher at the University of California, Los Angeles (UCLA). She returned to Finland in 1987 to establish a research group at the National Public Health Institute (KTL), where she served as the director of research until 1998.
In 1998, Peltonen-Palotie was appointed as the professor of medical genetics at the University of Helsinki. She also served as the head of the Department of Human Genetics at UCLA from 2003 to 2007.
Peltonen-Palotie's research focused on the genetics of human diseases. She made significant contributions to the understanding of several genetic disorders, including lactose intolerance, atherosclerosis, and schizophrenia.
Legacy[edit]
Peltonen-Palotie passed away in 2010, but her legacy continues to influence the field of human genetics. In recognition of her contributions, the Human Genome Organisation (HUGO) established the Leena Peltonen Prize for Excellence in Human Genetics in 2012.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
